Akero Therapeutics, Inc.
AKRO
$48.31
$0.280.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.16% | -7.64% | 3.60% | -5.65% | -15.88% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.03% | -1.63% | -7.89% | 87.41% | 107.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.21% | -7.43% | 3.15% | -3.75% | -14.84% |
|
|
|||||
| Total Current Assets | 7.21% | -7.43% | 3.15% | -3.75% | -14.84% |
| Net Property, Plant & Equipment | -9.87% | -8.74% | -9.58% | -7.22% | -6.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -4.04% | 39.95% | 1.02% | -5.49% | -5.17% |
|
|
|||||
| Total Accounts Payable | 22.32% | 19.98% | -64.21% | 73.14% | 5.70% |
| Total Accrued Expenses | 33.73% | -19.26% | 72.60% | 9.14% | 0.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4,539.80% | 2.75% | 2.83% | 2.91% | 3.00% |
| Total Finance Division Other Current Liabilities | 126.59% | 1.76% | -2.30% | -1.69% | -5.09% |
| Total Other Current Liabilities | 126.59% | 1.76% | -2.30% | -1.69% | -5.09% |
| Total Current Liabilities | 42.32% | 6.75% | -8.17% | 38.87% | 3.02% |
|
|
|||||
| Total Current Liabilities | 42.32% | 6.75% | -8.17% | 38.87% | 3.02% |
| Long-Term Debt | -23.08% | -18.38% | 0.50% | 0.47% | 0.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.52% | -14.74% | -12.56% | -10.90% | -9.47% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.14% | 52.58% | -4.43% | 23.78% | -7.87% |
| Total Liabilities | 15.75% | -4.98% | -4.35% | 18.28% | 1.49% |
|
|
|||||
| Common Stock & APIC | 0.64% | 25.67% | 5.56% | 0.72% | 0.54% |
| Retained Earnings | -7.86% | -8.56% | -9.26% | -10.64% | -8.92% |
| Treasury Stock & Other | -8.94% | 14.45% | -54.92% | 905.75% | -230.38% |
| Total Common Equity | -5.35% | 44.49% | 1.60% | -7.49% | -5.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.35% | 44.49% | 1.60% | -7.49% | -5.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.35% | 44.49% | 1.60% | -7.49% | -5.69% |
|
|
|||||